Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-12-15 Sale | 2020-12-17 6:58 pm | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $63.22 | $632,156 | 169,907 (Direct) | View |
2020-12-09 Sale | 2020-12-11 4:14 pm | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $45 | $450,000 | 179,907 (Direct) | View |
2020-12-07 Sale | 2020-12-08 4:12 pm | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 20,000 | $40.02 | $800,400 | 189,907 (Direct) | View |
2020-11-09 Sale | 2020-11-10 4:13 pm | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 228 | $31.21 | $7,116 | 24,907 (Direct) | View |
2020-10-15 Sale | 2020-10-16 4:38 pm | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 3,000 | $31.39 | $94,170 | 25,135 (Direct) | View |
2020-08-17 Sale | 2020-08-19 4:44 pm | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $35.29 | $352,900 | 213,135 (Direct) | View |
2020-08-06 Sale | 2020-08-10 4:24 pm | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,238 | $37.41 | $383,028 | 223,135 (Direct) | View |
2020-07-15 Sale | 2020-07-17 5:32 pm | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 3,000 | $32.22 | $96,660 | 28,373 (Direct) | View |
2020-05-06 Sale | 2020-05-08 4:17 pm | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 151 | $25.28 | $3,817 | 31,373 (Direct) | View |
2020-02-07 Sale | 2020-02-10 4:34 pm | Editas Medicine Inc. | EDIT | Albright Charles Chief Scientific Officer | 622 | $26.95 | $16,763 | 101,080 (Direct) | View |
2020-02-03 Sale | 2020-02-04 5:24 pm | Editas Medicine Inc. | EDIT | Albright Charles Chief Scientific Officer | 5,549 | $26.54 | $147,288 | 20,553 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-12-15 Exercise | 2020-12-17 6:58 pm | N/A 2026-09-08 | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $0 | 169,907 (Direct) | View |
2020-12-15 Exercise | 2020-12-17 6:58 pm | N/A N/A | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $16.51 | 169,907 (Direct) | View |
2020-12-09 Exercise | 2020-12-11 4:14 pm | N/A 2026-09-08 | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $0 | 179,907 (Direct) | View |
2020-12-09 Exercise | 2020-12-11 4:14 pm | N/A N/A | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $16.51 | 179,907 (Direct) | View |
2020-12-07 Exercise | 2020-12-08 4:12 pm | N/A 2026-09-08 | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 20,000 | $0 | 189,907 (Direct) | View |
2020-12-07 Exercise | 2020-12-08 4:12 pm | N/A N/A | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 20,000 | $16.51 | 189,907 (Direct) | View |
2020-08-17 Exercise | 2020-08-19 4:44 pm | N/A 2026-09-08 | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $0 | 213,135 (Direct) | View |
2020-08-17 Exercise | 2020-08-19 4:44 pm | N/A N/A | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $16.51 | 213,135 (Direct) | View |
2020-08-06 Exercise | 2020-08-10 4:24 pm | N/A 2026-09-08 | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $0 | 223,135 (Direct) | View |
2020-08-06 Exercise | 2020-08-10 4:24 pm | N/A N/A | Editas Medicine Inc. | EDIT | Albright Charles EVP/Chief Scientific Officer | 10,000 | $16.51 | 223,135 (Direct) | View |
2020-02-06 Option Award | 2020-02-10 4:34 pm | N/A 2030-02-05 | Editas Medicine Inc. | EDIT | Albright Charles Chief Scientific Officer | 81,149 | $0 | 101,080 (Direct) | View |
2020-01-31 Exercise | 2020-02-04 5:24 pm | N/A N/A | Editas Medicine Inc. | EDIT | Albright Charles Chief Scientific Officer | 17,977 | $0 | 20,553 (Direct) | View |